140710-90-3

• 常用中文名：3-O-叔丁基二甲基甲硅烷基骨化二醇
• 常用英文名：(6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-[tert-butyl(dimethyl)silyl]oxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptan-2-ol
• CAS号：140710-90-3
• 分子式：C₃₃H₅₈O₂Si
• 分子量：514.89800
• 发布时间：2017-09-22 10:42:30
• 更新时间：2026-07-24 07:24:47

名称

• 中文名: 3-O-叔丁基二甲基甲硅烷基骨化二醇
• 英文名: (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-[tert-butyl(dimethyl)silyl]oxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptan-2-ol
• 中文别名: 3-O-叔丁基二甲基甲硅烷基CALCIFEDIOL; 维生素D7杂质; 3-TBS-骨化二醇
• 英文别名: Vitamin D7 Injection; 3-O-TBDMS 25-OH Vitamin D3; 6-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-htan-2-ol; Calcifediol Impurity 5; 3-TBS-Calcifediol; (3β,5Z,7E)-3-[[(1,1-DiMethylethyl)diMethylsilyl]oxy]-9,10-secocholesta-5,7,10-triene-25-diol; 3-O-TBDMS 25; 3-O-tert-Butyldimethylsilyl-25-hydroxyvitamin D3; 3-O-tert-ButyldiMethylsilyl-25-hydroxyvitaMin D3; 3-O-tert-ButyldiMethylsilyl Calcifediol; 3-O-tert-ButyldiMethylsilyl-25-Hydroxycholecalciferol; 6-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cycl; (3|A,5Z,7E)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-9,10-secocholesta-5,7,10(19)-triene-25-diol; 3-O-tert-Butyldimethylsilyl Calcifediol; 3-O-tert-Butyldimethylsilyl-25-Hydroxycholecalciferol; 9,10-Secocholesta-5,7,10-trien-25-ol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3β,5Z,7E)- (9CI); (6R)-6-[(1R,3aS,4E,7-4-[(2Z)-2-[(5S)-5-[tert-butyl(dimethyl)silyl]oxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylhtan-2-ol

物化性质

• 分子式: C₃₃H₅₈O₂Si
• 分子量: 514.89800
• 精确质量: 514.42100
• PSA: 29.46000
• LogP: 9.76340
• 折射率: 1.508

合成路线

19356-17-3 ~% 140710-90-3

文献：Ray, Rahul; Lambert, James R. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 8 p. 2537 - 2540

上下游产品

上游产品  1
19356-17-3
下游产品  0